Nomura Holdings Inc. Acquires New Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Nomura Holdings Inc. bought a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 295,919 shares of the company's stock, valued at approximately $3,882,000. Nomura Holdings Inc. owned 0.34% of Pediatrix Medical Group at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. raised its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares during the last quarter. AlphaQuest LLC grew its holdings in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after acquiring an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after buying an additional 5,104 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Truist Financial decreased their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, UBS Group cut their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Stock Performance

NYSE MD traded up $0.11 during trading on Wednesday, reaching $15.27. 330,327 shares of the company's stock were exchanged, compared to its average volume of 849,436. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a market capitalization of $1.31 billion, a P/E ratio of -12.72, a PEG ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The business has a 50 day moving average price of $13.75 and a 200-day moving average price of $14.12.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company's quarterly revenue was down 7.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.20 EPS. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.